CN107260792A - The composition of mouth disease is prevented or treated to being used for comprising natural complex - Google Patents
The composition of mouth disease is prevented or treated to being used for comprising natural complex Download PDFInfo
- Publication number
- CN107260792A CN107260792A CN201710202985.XA CN201710202985A CN107260792A CN 107260792 A CN107260792 A CN 107260792A CN 201710202985 A CN201710202985 A CN 201710202985A CN 107260792 A CN107260792 A CN 107260792A
- Authority
- CN
- China
- Prior art keywords
- composition
- extract
- mouth disease
- treated
- prevented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 134
- 208000030194 mouth disease Diseases 0.000 title claims abstract description 45
- 239000000284 extract Substances 0.000 claims abstract description 224
- 241000628997 Flos Species 0.000 claims abstract description 79
- 240000005528 Arctium lappa Species 0.000 claims abstract description 39
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 39
- 241000207925 Leonurus Species 0.000 claims abstract description 32
- 239000004480 active ingredient Substances 0.000 claims abstract description 28
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 26
- 210000000214 mouth Anatomy 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 229940034610 toothpaste Drugs 0.000 claims description 20
- 239000000606 toothpaste Substances 0.000 claims description 20
- 208000007565 gingivitis Diseases 0.000 claims description 19
- 206010006326 Breath odour Diseases 0.000 claims description 18
- 208000032139 Halitosis Diseases 0.000 claims description 18
- 238000009472 formulation Methods 0.000 claims description 18
- 241000194017 Streptococcus Species 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 11
- 241000605894 Porphyromonas Species 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 201000001245 periodontitis Diseases 0.000 claims description 8
- 241000605862 Porphyromonas gingivalis Species 0.000 claims description 7
- 208000004371 toothache Diseases 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 208000025865 Ulcer Diseases 0.000 claims description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 231100000397 ulcer Toxicity 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 26
- 230000001225 therapeutic effect Effects 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 10
- 230000006806 disease prevention Effects 0.000 abstract description 6
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 229930014626 natural product Natural products 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 description 30
- 244000046146 Pueraria lobata Species 0.000 description 28
- 235000010575 Pueraria lobata Nutrition 0.000 description 28
- 238000002360 preparation method Methods 0.000 description 25
- 241000894006 Bacteria Species 0.000 description 21
- -1 allantoin chloro hydroxy aluminate Chemical class 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000000306 component Substances 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- 244000223014 Syzygium aromaticum Species 0.000 description 13
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 13
- 235000017352 Telosma cordata Nutrition 0.000 description 13
- 240000006688 Telosma cordata Species 0.000 description 13
- 238000000605 extraction Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 235000013599 spices Nutrition 0.000 description 11
- 235000003599 food sweetener Nutrition 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- 239000003765 sweetening agent Substances 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 7
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000004088 foaming agent Substances 0.000 description 7
- 238000000227 grinding Methods 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 201000006727 periodontosis Diseases 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 210000004268 dentin Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 239000002324 mouth wash Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 241000194019 Streptococcus mutans Species 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 5
- 229960002986 dinoprostone Drugs 0.000 description 5
- 239000006072 paste Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 5
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 239000000375 suspending agent Substances 0.000 description 5
- 239000000080 wetting agent Substances 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 208000035154 Hyperesthesia Diseases 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229960003260 chlorhexidine Drugs 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 229960000414 sodium fluoride Drugs 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 241000194023 Streptococcus sanguinis Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 235000019204 saccharin Nutrition 0.000 description 3
- 229940081974 saccharin Drugs 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 241000606750 Actinobacillus Species 0.000 description 2
- 241000186046 Actinomyces Species 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Chemical class 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantion Natural products NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 229940029982 garlic powder Drugs 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000001683 mentha spicata herb oil Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229940084560 sanguinarine Drugs 0.000 description 2
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 2
- 235000019721 spearmint oil Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001014327 Anodontia Species 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000234653 Cyperus Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical class CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000598921 Homo sapiens Orexin Proteins 0.000 description 1
- 101001123245 Homo sapiens Protoporphyrinogen oxidase Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000003941 Impacted Tooth Diseases 0.000 description 1
- 240000003271 Leonurus japonicus Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102100029028 Protoporphyrinogen oxidase Human genes 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 208000004188 Tooth Wear Diseases 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 241001302463 Viola mandshurica Species 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- RBLGLDWTCZMLRW-UHFFFAOYSA-J [OH-].[OH-].P(=O)([O-])([O-])O.[Ca+2].[Ca+2] Chemical compound [OH-].[OH-].P(=O)([O-])([O-])O.[Ca+2].[Ca+2] RBLGLDWTCZMLRW-UHFFFAOYSA-J 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical group Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 206010002583 anodontia Diseases 0.000 description 1
- 230000005212 anodontia Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000011797 cavity material Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- IPGANOYOHAODGA-UHFFFAOYSA-N dilithium;dimagnesium;dioxido(oxo)silane Chemical compound [Li+].[Li+].[Mg+2].[Mg+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O IPGANOYOHAODGA-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940076522 listerine Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000004261 periodontium Anatomy 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000003186 pharmaceutical solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of composition for preventing or treating mouth disease comprising natural complex of present invention offer, the composition for being used to preventing or treating mouth disease of the invention, it includes (i) Flos puerariae lobatae extract or (ii) Flos Caryophylli extract;And one or more of the group extract constituted selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and Leonurus extract is as active ingredient, the mouth disease prevention of composition of the invention or therapeutic effect are excellent.In addition, the composition of the present invention is the material that natural products is originated, thus it is nontoxic, side effect is not also induced even if suitable for human body, therefore utilization rate is high.
Description
Technical field
The present invention relates to mouth disease prevention and/or therapeutic composition.
Background technology
As the theory of dental health is changed into social life theory, increase is focused on to oral health, not only counterpart
Chamber prevention and treatment of diseases focuses on increase, and for carrying out the obstacle as important interpersonal relationships during social life
The concern of halitosis is also in increase.
Dental tissue is made up of enamel, cementum and dentine.The outside for being exposed to the tooth of outside is covered by enamel,
The outside of root of the tooth part in alveolar bone is covered by cementum, there is dentine inside it.In dentine, it is referred to as tooth
The fine pipe of tubule is distributed in the range of whole dentine.
Carious tooth and periodontosis in mouth disease are used as induction pain, masticatory movement obstacle, the destruction of periodontium, halitosis
And the various clinical symptom such as hemodia and cause the principal element of anodontia known, due to the change of dietetic life,
The risk factor of carious tooth is continuing to increase.
As to perched in bacterial plaque and induce carious tooth, the Oral Pathogens of periodontosis, halitosis and hemodia are bred
The method suppressed, a variety of antibiotic preparations comprising the antibiotic to these bacteriums with sterilization and bacteriostasis effect are developed to
Carious tooth, periodontosis, suppression and the therapeutic agent of tooth marrow and apical infection.
But, antibiotic can induce the appearance of drug-fast bacteria in the side effect to the whole body of human body and oral cavity and repeat to feel
Dye, therefore have the shortcomings that not being used for a long time and be used only as therapeutic agent.In addition, being used as the antibacterial used in mouth washes
Preparation has sanguinarine (Sangquinarine), Li Shidelin (Listerine), peroxide (Peroxide), Chlorhexidine
(Chlorhexidine) etc., but effect of the sanguinarine to bacterium in oral cavity is indefinite, when occurring periodontosis to therapeutic effect
It is less well defined, and have the shortcomings that price is high, Li Shidelin is using ethanol as main component, and actual shown in oral cavity is faced
When effect, with a little bacteriostasis, but when being used for a long time damaging effect showed to tissue, and be used for whitening effect recently
Although and the peroxide added has toxic action to bacterium but while toxic action is still shown to tissue, not only
There is problem in security, can also show the drug-fast bacteria to peroxide in bacterium sometimes.In addition, Chlorhexidine is used as tooth bacterium
Spot formation suppresses and periodontosis prevention and treatment agent is that to be currently known preparation most excellent in preparation known, but exists pair
The stimulation of tissue, the coloring of tissue and modification, especially show that excitant is strong, smell weight side effect, in addition may be used also
Superinfection can be induced, with carcinogenicity, thus limited etc. for the use of pregnant woman, it is impossible to as treatment or especially to prevent mesh
Long-term use.
Thus, the present inventor in order to export be not present side effect as described above and to mouth disease, i.e. toothache, carious tooth,
Gingivitis, periodontitis, mucosal ulcer, halitosis, hemodia etc. have the natural of excellent prevention and/or therapeutic effect in oral cavity
Material and studied.
Prior art literature
Patent document
Patent document 1:KR published patent the 10-2015-0050995th
Patent document 2:KR published patent the 10-2013-0105622nd
The content of the invention
Thus, it is an object of the present invention to provide this useful use of a kind of new active component, i.e. active component
On the way, the problem of it can solve the problem that as described above, few side effects and safe to the human body, additionally it is possible to suppress the growth of oral cavity bacterium.
In other words, it is an object of the present invention to provide being used as active ingredient comprising the excellent active component of above-mentioned effect
Composition.
It is an object of the invention to provide a kind of composition, it can be safe to use using safety in vivo it is natural come
Derived components, treatment or improvement for mouth disease.
It is an object of the invention to provide a kind of composition for oral cavity, it utilizes natural material in the dental surface shape of damage
Into film, hemodia symptom can be alleviated.
To realize the purpose, the composition for being used to preventing or treating mouth disease of the invention, it includes flower of kudzuvine extraction
Thing is used as active ingredient.
To realize the purpose, the composition for being used to preventing or treating mouth disease of the invention, it includes flower of kudzuvine extraction
Thing and Flos Caryophylli extract are used as active ingredient.
To realize the purpose, the composition for being used to preventing or treating mouth disease of the invention, it includes cloves extraction
Thing and selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and Leonurus extract constitute group in
More than one extracts are used as active ingredient.
To realize the purpose, the present invention provides a kind of composition for oral cavity in natural materials source.Specifically, this hair
Composition for oral cavity is provided in a bright embodiment, it is used as active ingredient comprising flower of kudzuvine (Pueraria).
That is, the present invention provides the composition for oral cavity for including flower of kudzuvine, is provided in particular in being used to preventing, improve or treating a variety of
The new application of the composition for oral cavity of mouth disease.
In another embodiment, the present invention provides a kind of composition for being used to preventing and/or treating mouth disease, preferably
A kind of composition for oral cavity, cosmetic composition, pharmaceutical composition or health-care food composition are provided, it is included:(i) flower of kudzuvine carries
Take thing;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
One or more of the group that careless extract is constituted extract is used as active ingredient.
That is, the present invention provides a kind of new application for being used to preventing and/or treating mouth disease, and it is included:(i) flower of kudzuvine is extracted
Thing;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
One or more of the group that careless extract is constituted extract.
Cloves (Syzygium aromaticum Merrill et Perry) refers to the sub- arbor cloves tree of tropical evergreen
Bud part, Mo Lujiazhu islands are original producton location, originate in the Sang Jiba islands of Tanzania, Indonesian Sumatera, Brazil,
Malaysia, Philippine, Vietnam, SOUTHERN CHINA etc..
Above-mentioned flower of kudzuvine refers to the bud or firm blooming flower of the root of kudzu vine (Pueraria lobata Ohwi), it is preferable that above-mentioned
The bud of the root of kudzu vine after drying can be used in flower of kudzuvine.For each position of plant, its effect, effect are different, of the invention
The root of flower of kudzuvine and the root of kudzu vine, the leaf of the root of kudzu vine are different without bitter taste, thus are adapted to be used in composition for oral cavity, by grinding for a long time
The result studied carefully can confirm that out, compared with other positions of the root of kudzu vine, with excellent antibacterial activity and hemodia prevention and
Improvement is remarkable.Especially, there is remarkable antibacterial effect to carious tooth pathogen.
Great burdock achene refers to the fruit of the great burdock achene (Arctium lappa Linne) as composite family (Compositae) plant
It is real, also referred to as dislike real.
Chinese violet refers to the violet (Viola mandshurica W.Becker) or Chinese violet (Viola of Violaceae
Yedoensis Makino) whole strain.Chinese violet has slightly special smell, with excitant, bitter, pungent, cool in nature.
Motherwort (Chinese motherwort) is by the motherwort (Leonurus of Labiatae (Labiatae)
Sibiricus L) aerial part when the flowers are in blossom dries.Motherwort has slightly special smell, bitter, pungent, Bearberry Extract
Property, slightly cool in nature.
The inventors discovered that, in use (i) Flos puerariae lobatae extract and (ii) Flos Caryophylli extract and selected from Flos puerariae lobatae extract, ox
In the case of one or more of the group that burdock seed extract, Herba Violae extract and Leonurus extract are constituted extract,
There is excellent effect to mouth disease, it is preferable that Flos Caryophylli extract, Flos puerariae lobatae extract, burdock extract, Chinese violet are extracted
The mixed extract of thing and Leonurus extract has the biological activity of most excellent collaboration.
In the present invention, term " extract " includes handling by said extracted and extract solution, the said extracted liquid of acquisition
Dilution or concentrate, the drying liquid that said extracted liquid is dried and obtained, the conditioning agent product of said extracted liquid or essence
Refine the extract of thing or their mixture etc., extract solution itself and all formulations that can be formed using extract solution.
Said extracted thing in addition to specific position, can also include its leaf, stalk, tree when illustrating each plant
Skin, root, flower or bud, fruit, seed, resin and whole plant.
In order to prepare said extracted thing, any appropriate method well known in the art can be used in those skilled in the art.Example
Such as, it is possible to use gas phase extraction process or solvent extraction method.After plant entirety or arbitrary portion are crushed (for example, stirring), use
Extraction solvent is handled, so as to obtain solvent extractable matter.Can also be before crushing, by drying process (for example, 40
Dried 15 to 50 hours to 70 DEG C) crushed afterwards.In addition, solvent extractable matter can pass through vacuum distillation and freeze-drying
Or the additive proccess such as spray drying is prepared into pulverulence.
The species of Extraction solvent is not particularly limited used in above-mentioned, can be used as known in the art arbitrary molten
Agent.Water can be used as the non-limiting example of said extracted solvent;The C1 such as methanol, ethanol, propyl alcohol, butanol to C4 are rudimentary
Alcohol;The polyalcohols such as glycerine, butanediol, propane diols;And methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, dichloro
The hydrocarbon system solvents such as methane;Or their mixture, it is preferable that it can be used alone water, lower alcohol or by two or more mixing
Use.It can be used more than above-mentioned solvent extraction once to prepare solvent extractable matter, can also prepare and subtract above-mentioned solvent extractable matter
The dried extract for being freeze-dried after pressure distillation or being spray-dried and being obtained.
The amount of said extracted solvent can be different according to the species of used Extraction solvent, for example, can be planted relative to target
The dry weight of thing uses 1 to 20 times, or 5 to 20 times.
Furthermore, it is possible to select using a variety of extraction processes well known in the art, for example impregnate (maceration), immersion
(infusion), infiltration (percolation), digestion, decoction (decoction), high temperature continuously extract (hot continuous
Extraction it is), aqueous-alcohol repellency extract, adverse current extraction, microwave radiation exaraction, ultrasonic wave extraction, supercritical fluid extraction,
Tissue extracts (phytonic extract) (such as fluorinated hydrocarbon solvent)) etc., they can be performed separately or by two kinds
Above method simultaneously is used for performing.
The composition of the present invention includes (i) Flos puerariae lobatae extract;Or (ii) Flos Caryophylli extract;And extracted selected from flower of kudzuvine
One or more of the group that thing, burdock extract, Herba Violae extract and Leonurus extract are constituted extract conduct
Active ingredient, preferably comprises Flos Caryophylli extract;And selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract with
And one or more of the group extract that Leonurus extract is constituted is as active ingredient, more preferably comprising Flos Caryophylli extract, Pueraria lobota
Flower extract, burdock extract, Herba Violae extract and Leonurus extract are used as active ingredient.
In the present invention, " comprising active ingredient is used as " refers to, can show outlet plenum disease using the composition of the present invention
The degree of disease prevention and/or therapeutic effect adds extract, and he is to include to stabilize etc. and add Multiple components conduct
Accessory ingredient simultaneously can be with variform formulation (formulation).
The composition of the present invention can include 0.0001 to 1 weight % active ingredient relative to composition total weight, preferably
0.0005 to 0.5 weight % can be included, 0.001 to 0.1 weight % can be more preferably included.
In the preferred embodiment of the present invention, comprising Flos Caryophylli extract, Flos puerariae lobatae extract, burdock extract,
Herba Violae extract and Leonurus extract, can be by following ratio bags as in the composition of the invention of active ingredient
Containing each plant extracts.For example, Flos Caryophylli extract:Flos puerariae lobatae extract:Burdock extract:Herba Violae extract:It is beneficial female
The weight ratio of careless extract can include 1:0.1~10:0.1~10:0.1~10:0.1~10.
The composition of the present invention can be used to preventing, improve and/or treating mouth disease.
In the present invention, above-mentioned mouth disease is including but not limited to toothache, carious tooth, gingivitis, periodontitis, mucous membrane in oral cavity
The concept of ulcer, halitosis, hemodia etc..
The composition of the present invention preferably can be used as gingivitis and/or periodontitis prevention, treatment and/or improve purposes.
Though for example, not limited to this, it may include the halitosis caused by the microorganism in oral cavity, mucous membrane is burst in carious tooth and oral cavity
Ulcer etc..
In addition, above-mentioned mouth disease is in addition to the disease caused by microorganism in oral cavity, also it can include because of external physical
Caused a variety of disease in mouth are stimulated, it is anti-to show allergy such as it can also include canaliculi dentales and expose because being worn away dental surface
The hemodia symptom answered.
In the present invention, term " prevention " refers to all behaviors for suppressing or delaying disease using above-mentioned composition.
In addition, in the present invention, term " treatment " refers to make the institute of remission or the healing of disease using above-mentioned composition
There is behavior.
In addition, term " improvement " as used in this specification refers to that hemodia symptom as described above is reduced or subtracted
Weak, it is understood to include the wide concept of alleviation, prevention, treatment etc..
In the present invention, term " toothache " refers to the pain occurred on tooth, the pain occurred when generally representing to chew on tooth
Bitterly.The reason for toothache, is not limited to this, including carious tooth, tooth marrow inflammation, impacted tooth, tooth folding, tooth wear disease etc..The present inventor confirms
Going out the composition of the present invention has excellent inhibitory action to the PGE2 of the index as toothache.
In the present invention, term " carious tooth " refers to that tooth is damaged because of oral cavity bacterium, and thus produces carious tooth.For example,
The bacterial plaque (plaque) that dental surface is generated as biomembrane can be one of reason.Above-mentioned oral cavity bacterium not limited to this,
But can be streptococcus (Streptococcus) category, porphyromonas (Porphyromonas) category etc..
In the present invention, term " gingivitis " and " periodontitis " are bacterium, such as streptococcus being present in subgingival plaque
(Streptococcus) bacterium such as category, porphyromonas (Porphyromonas) category is when forming suitable growth conditions, in tooth
The soft tissue at gum position causes infection, develops into the periodontosis of gingivitis or periodontitis, so as to cause the oral cavity of the inflammation of gum
Disease.Gingivitis, which deteriorates, becomes periodontitis.
In the present invention, term " halitosis " refers to that it is residual due to the protein in posteriori general disease or saliva, food
The material that slag etc. is decomposed by the microorganisms and generated in oral cavity is decomposed, and thus generation induces the material of stench and occurs halitosis.
As induce halitosis one-level reason oral cavity in microorganism do not limit, its can be streptococcus (Streptococcus) category,
Porphyromonas (Porphyromonas) category, actinomyces (Actinomyces) category, Actinobacillus (Actinobacillus) category etc..
In the present invention, term " hemodia " not limited to this, but represent due to carious tooth or other causes for pathological and in addition
Outside stimulus and show sensitivity pain temporarily or continuously all phenomenons.Said external, which is stimulated, generally represents temperature thorn
Swash, symptom substantially is triggered to cool thermal stimulus, can also show pain at the temperature of heat sometimes.Except this thermal stimulus
In addition, dry because of tooth, contact with exterior materials, pain also occurs in the stimulation such as osmotic pressure based on sweet tea or peppery food.Its
Occur on all positions of whole tooth, can also be defined in the appearance of the privileged sites such as maxilla or lower jaw or right side or left side, also
Can be with dentine hyperesthesia (dentine hyperesthesia), caries, tooth marrow inflammation.The present inventor confirms
Go out, above-mentioned Flos puerariae lobatae extract can react with the calcium ion included in saliva and form film, the film of formation in dental surface
Exposing for canaliculi dentales is blocked, so as to prevent, improve or treat hemodia symptom.
Term " mucosal ulcer in oral cavity " as used in this specification is also known as stomatitis (stomatitis), though do not limit
In this, but it is also possible to including caused by oral cavity bacterium, virus, mould etc. infection and in oral cavity mucous membrane (tongue, gum, mouth
Lip, on the inside of cheek etc.) produce the disease of inflammation.
Above-mentioned mouth disease, which has, to be induced by bacterium, and above-mentioned bacterium can be streptococcus (Streptococcus) category bacterium.
The composition of the present invention belongs to streptococcus (streptococcus) or porphyromonas (Porphyromonas) belongs to, more
Specifically to selected from Streptococcus mutans (streptococcus mutans), Streptococcus sanguis (streptococcus
Sanguis), blood red streptococcus (Streptococcus sanguinis), saliva chain coccus thermophilous subspecies (Streptococcus
Salivarius subsp.thermophils) and porphyromonas gingivalis (Porphyromonasgingivalis) composition
One or more of group bacterium there is remarkable antibacterial effect, thus confirm to have for prevention and treatment mouth disease excellent
Different effect.
It is highly preferred that being gone out by experimental verification, composition of the invention is to Streptococcus mutans (streptococcus
) or porphyromonas gingivalis (Porphyromonasgingivalis) bacterium has remarkable antibacterial effect mutans.
The composition of the present invention can be composition for oral cavity.
Above-mentioned composition for oral cavity, according to its formulation and application target, generally may be used in addition to comprising above-mentioned active ingredient
Further comprise as the wetting agent of composition, grinding agent, drug effect agent, sweetener, pH adjusting agent, preservative, binding agent, spices, foaming
Agent etc..
As wetting agent, it is used alone or as a mixture selected from concentrated glycerin, glycerine, sorbitol aqueous solution, amorphism sorbierite
Material in the group that the aqueous solution, polyethylene glycols and propane diols are constituted, its usage amount is relative to composition for oral cavity gross weight
1 to 70 weight % can be included.
As grinding agent, it can use selected from sedimentation silica, silica gel, zirconium silicate, calcium monohydrogen phosphate, anhydrous phosphoric acid hydrogen
The group that calcium, aqueous alumina, precipitated calcium carbonate, powdered whiting, calcium pyrophosphate, insoluble metaphosphate and alumina silicate are constituted
In one kind etc..The usage amount of such grinding agent, which is commonly angled relative to composition for oral cavity gross weight, can include 1 to 60 weight %.
In addition, as the additive used on a small quantity, it can include and be used as the drug effect agent of usually used composition, sweetener, pH adjusting agent, anti-
Rotten agent, colouring agent, foaming agent, binding agent etc., it can include 0.001 to 3 weight % relative to composition for oral cavity gross weight.
Drug effect agent can be by sodium fluoride, sodium monofluorophosphate, sodium fluoride, stannous fluoride, Chlorhexidine, allantoin chlorine hydroxy Al
(allantoin chloro hydroxy aluminate), aminocaproic acid, zinc chloride, puridoxine hydrochloride, tocopherol acetate, enzyme
Class etc. is mixed and used alone or in any combination.
As binding agent, sodium cellulose glycolate, carbomer, carragheen, xanthans, alginic acid salt etc. can be used, is made
, can be by sodium alkyl sulfate, lauryl sodium sulfate, sucrose fatty ester, sorbitan fatty ester for foaming agent
The anion and nonionic surfactant of (sorbitan monoester alkoxylate) etc. are mixed alone or in any combination
And use.
As sweetener, saccharin, xylitol, antierythrite, Aspartame etc. can be used.
As pH adjusting agent, sodium phosphate, disodium hydrogen phosphate, citric acid, triethanolamine etc. can be used.
As preservative, benzoic acid, methyl p-hydroxybenzoate, propylparaben, sodium benzoate can be used
Deng.As spices, peppermint oil, spearmint oil, menthol etc. can be mixed and used, as other additives, can also made
With enzymes such as dextranases (dextranase).
As foaming agent, lauryl sodium sulfate as anionic surfactant can be used, as nonionic
Property the copolymer (poloxamer) of polyethylene glycol oxide PPOX of surfactant, polyoxyethylene hydrogenated castor oil, poly-
Ethylene oxide sorbitan fatty acid ester etc..
In addition, the water comprising surplus.
In addition, the present invention provides the product of oral cavity for including above-mentioned composition.
Include (i) Flos puerariae lobatae extract;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
One or more of the group that careless extract is constituted extract as active ingredient composition for oral cavity of the invention as
The composition of oral hygiene, its can be all contained in prepared generally for oral health, commercially available product, to be applicable mouth
Chamber is not limited with product (oral hygiene product).
For example, as above-mentioned product of oral cavity, including toothpaste, mouthspray liquid, mouthwass, oral cavity ointment, mouth
Chamber paster, mouth washes, product of gargling, chewing gum etc., but not limited to this.The product of oral cavity of the present invention can be liquid
State, solid-state, suspension, gel, aerosol form, but not limited to this.
The present invention oral hygiene composition be toothpaste type in the case of, except comprising Flos puerariae lobatae extract as effectively into
Beyond point, grinding agent, binding agent, NMF, foaming agent, sweetener, whitening agent or flavouring agent can be additionally included.As above-mentioned
Grinding agent, can individually or compound use aluminium hydroxide, silica, alumina silicate, Dicalcium Phosphate dihydroxide and acid anhydride, tricresyl phosphate
Calcium, calcium carbonate, calcium pyrophosphate, insoluble sodium metaphosphate, tricresyl phosphate magnesium, magnesium carbonate, calcium sulfate, polymethyl methacrylate etc..
The content of above-mentioned grinding agent typically 20 weight % on the basis of total composition are not limited to above-mentioned contain to 90 weight %
Amount.
In the case where above-mentioned oral hygiene composition is paste-like composition, above-mentioned binding agent can individually or compoundly make
With carragheen, the gummy class of various thickenings cellulose derivative, xanthans, bassora gum (tragacanthgum) etc.;Polyethylene
The organic system binding agents such as the synthesis polymeric derivative such as alcohol, Sodium Polyacrylate, polyacrylic acid/maleic acid, carbopol
And inorganic system's binding agent such as silica, lithium magnesium silicate etc..The content of above-mentioned binding agent generally may be used on the basis of total composition
0.3 weight % is thought to 5 weight %, but is not limited to above-mentioned content.
In addition, above-mentioned oral hygiene composition is when it is prepared, can further comprise as the D-sorbite of NMF, glycerine,
Ethylene glycol, propane diols, PPG, polypropylene glycol etc..
In addition, can be additionally comprising spices or sweetener etc. in above-mentioned oral hygiene composition.Above-mentioned sweetener can be
Sucrose, lactose, maltose, D-sorbite, xylitol, sodium cyclohexylsulfamate, glycerine, saccharin sodium, stevioside, Aspartame
Deng, above-mentioned spices can be peppermint, menthol, anethole, eugenol, limonene, citronellol, alpha-terpineol, gaultherolin,
Cineole, linalool, ethyl linalool, vanillic aldehyde, thymol, spearmint oil, cyperus oil, rosemary oil, cassia oil etc., it is above-mentioned
Sweetener or spices can individually or compoundly be used.
In addition, can be individually or compoundly comprising the surface used as foaming ingredient in the oral hygiene composition of the present invention
Activating agent or additional functional component.The surfactant used as above-mentioned foaming ingredient can be selected from anion surface active
Any of group that agent, nonionic surfactant and cationic surfactant are constituted.
In the case where the oral hygiene composition of the present invention is toothpaste, except including (i) Flos puerariae lobatae extract;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
Beyond one or more of the group that careless extract is constituted extract is as active ingredient, can by conventional toothpaste preparation method come
Prepare, in the case where the oral hygiene composition of the present invention is mouthwash solution, flower of kudzuvine can be mixed in common pharmaceutical solutions
Extract and formulation turn to mouthwash solution and prepared, and by one day to mouth washes 2 to 10 times, can prevent or treat mouth
Chamber disease.
In addition, in the case where the oral hygiene composition of the present invention is toothpaste, can also include containing water and NMF
Liquid, gelling agent or water-insoluble brightener, sweetener, spices etc..
In addition, in the case where the oral hygiene composition of the present invention is mouth washes (cleaning agent), can also include tooth
Cream base, more specifically can additionally include non-toxic ethanol.
The method of the oral disease therapeutic or prevention composition that prepare the present invention can lead to according in this area for preparing it
It is prepared by the method that often uses.
In addition, the composition of the present invention can be cosmetic composition.
The above-mentioned composition for being used to preventing and/or treating mouth disease is using selected from solution, externally-applied ointment, emulsifiable paste, bubble
Foam, nutrition toner, soft toner, face cream, softened water, emulsion, foundation cream, Essence, soap, liquid ceanser, shower
Dew, suncream, skin care oil, suspension, emulsion, paste, gel, lotion, powder, soap, the washing cream containing surfactant,
It is prepared by formulation in the group that oil, powder cream base, emulsion foundation frost, wax powder cream base, patch and spray liquid are constituted, but
Not limited to this.
In addition, the cosmetic composition of the present invention can be additionally comprising generally with the cosmeceutical being mixed in cosmetics for skin
More than one admissible substrate, as common composition, for example, can suitably be compounded oil, water, surfactant, guarantor
Humectant, lower alcohol, thickener, chelating agent, pigment, preservative, spices etc., but not limited to this.
The admissible substrate of cosmeceutical included in the cosmetic composition of the present invention is different according to formulation.In this hair
In the case that bright formulation is ointment, paste, emulsifiable paste or gel, as substrate component, animality oil, vegetalitas can be used
Oil, wax, paraffin, starch, tragacanth (Tragacant), cellulose derivative, polyethylene glycol, silicon, bentonite, silica, cunning
Stone, zinc oxide or their mixture.
In the case where the formulation of the present invention is powder or spray liquid, as substrate component, can use lactose, talcum,
Silica, aluminium hydroxide, calcium silicates, polyamide powder or their mixture, the situation particularly with spray liquid can be chased after also
Plus ground includes the propellants such as chlorine fluorohydrocarbon, propane/butane or dimethyl ether.
In the case where the formulation of the present invention is solution or emulsion, as substrate component, solvent, solubilizer or emulsification are used
Agent, for example, have water, ethanol, isopropanol, diethyl carbonate, ethyl acetate, Ergol, propane diols, 1,3- butyl glycols
Oil, in particular cottonseed oil, peanut oil, corn semina oil, olive oil, castor oil and sesame oil, fatty acid glyceride, poly- second
The fatty acid ester of glycol or anhydrosorbitol.
In the case where the formulation of the present invention is suspension, as substrate component, such as water, ethanol or the third two can be used
Diluent, ethoxylated isostearyl alcohols, polyoxyethylene sorbitol ester and such as polyethylene glycol oxide dehydration mountain of the liquid of alcohol
The suspending agent of pears sugar alcohol ester, fine crystal cellulose, inclined aluminium hydroxide (aluminum methahydroxide), bentonite,
Agar or tragacanth etc..
In addition, the composition of the present invention can be pharmaceutical composition.
According to another embodiment of the present invention, the present invention, which is provided, contains (i) Flos puerariae lobatae extract;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
One or more of the group that careless extract is constituted extract as active ingredient the medicine for being used to preventing and/or treating mouth disease
Compositions.
The present invention's includes (i) Flos puerariae lobatae extract;Or (ii) Flos Caryophylli extract;And selected from Flos puerariae lobatae extract, burdock
The composition of one or more of the group that seed extract, Herba Violae extract and Leonurus extract are constituted extract can be with
It is oral or para-oral a variety of formulations.Carry out it is formulation in the case of, using commonly used filler, swelling agent,
It is prepared by the diluents such as binding agent, wetting agent, disintegrant, surfactant or excipient.Solid-state for oral administration
Preparation includes tablet, pill, powder, granule, capsule etc., and such solid formulation is mixed in more than one compounds
Come including at least more than one excipient, such as starch, calcium carbonate, sucrose (sucrose) or lactose (lactose), gelatin
Prepared.In addition, except the simple excipient, also using the lubricant of magnesium stearate, talcum etc..As for passing through
The liquid formulation of mouthful administration has suspending agent, interior use liquor, emulsion, syrup etc., except conventional water as simple diluent,
Beyond atoleine, a variety of excipient can be also included, such as wetting agent, sweetener, aromatic, preservative.For non-oral
The preparation of administration includes the aqueous solution, non-aqueous solvent, suspending agent, the emulsion of sterilizing., can as non-aqueous solvent, suspension agent
With using plant oil such as propane diols (propyleneglycol), polyethylene glycol, olive oil, ethyl oleate can
The ester of injection.
The present invention can also be provided for preventing and/or treating the formulation of the skin preparations for extenal use of mouth disease, and it is included
Above-mentioned (i) Flos puerariae lobatae extract;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
One or more of the group that careless extract is constituted extract is used as active ingredient.
(i) Flos puerariae lobatae extract is being included by above-mentioned;Or (ii) Flos Caryophylli extract;And selected from Flos puerariae lobatae extract, burdock
The composition conduct of one or more of the group that seed extract, Herba Violae extract and Leonurus extract are constituted extract
In the case of skin preparations for extenal use use, can also additionally containing fatty material, organic solvent, lytic agent, concentrating agents and gelling agent,
Softening agent, antioxidant, suspending agent, stabilizer, foaming agent (foaming agent), aromatic, surfactant, water, ionic
Or nonionic emulsifier, filler, sequestering agent and chelating agent, preservative, vitamin, retarding agent, wetting agent, essence
Oil, dyestuff, pigment, hydrophily or lipophile activating agent, lipid folliculus are typically used as the such as any of skin external preparation
The commonly used preservative in Dermatology field of other compositions.In addition, mentioned component can be with Dermatology field
In commonly used amount imported.
In above-mentioned (i) Flos puerariae lobatae extract;Or (ii) Flos Caryophylli extract;And extracted selected from Flos puerariae lobatae extract, great burdock achene
One or more of the group that thing, Herba Violae extract and Leonurus extract are constituted extract is carried with skin preparations for extenal use formulation
For in the case of, can have the formulation of such as ointment, patch, gel, emulsifiable paste or spray, but not limited to this.
The pharmaceutical composition of the present invention can be used as non-oral use preparation, and for example skin preparations for extenal use can be by by vaseline, hard
The suitable preparation that lipidol etc. pharmaceutically allows;The suitable table that polysorbate, Sorbitan Sesquioleate etc. pharmaceutically allow
Face activating agent;The suitable NMF that glycerine etc. pharmaceutically allows;The suitable solvent pharmaceutically allowed;And flavor component,
It is prepared by the preparation method of the common skin preparations for extenal use that colouring agent, stabilizer, thickening agent etc. are equably mixed.
The pharmaceutical composition of the present invention is in above-mentioned (i) Flos puerariae lobatae extract comprising effective dose;Or (ii) Flos Caryophylli extract;
And one in the group constituted selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and Leonurus extract
In the case of the extract for planting the above, using the teaching of the invention it is possible to provide preferred mouth disease prevention and/or therapeutic effect.In the present invention, " effectively
Amount " is the amount for referring to fully show mouth disease prevention and/or therapeutic effect.
Above-mentioned (i) Flos puerariae lobatae extract included in the composition of the present invention;Or (ii) Flos Caryophylli extract;And be selected from
One or more of group that Flos puerariae lobatae extract, burdock extract, Herba Violae extract and Leonurus extract are constituted carries
The effective dose of thing is taken to be applied to the method for skin by the form of commercialization, above-claimed cpd according to composition and be trapped in skin
On time etc. and it is different.For example, in the case where above-mentioned composition is made into medicine, with being normally manufactured as being applied to skin
The situation of the cosmetics of skin is compared, and above-mentioned (i) Flos puerariae lobatae extract can be included in the way of high concentration;Or (ii) cloves is extracted
Thing;And in the group constituted selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and Leonurus extract
More than one extracts.
According to another embodiment of the present invention there is provided a kind of health food for being used to preventing and/or treating mouth disease, its
Include above-mentioned (i) Flos puerariae lobatae extract;Or (ii) Flos Caryophylli extract;And selected from Flos puerariae lobatae extract, burdock extract, pale reddish brown
One or more of the group that Chinese violet extract and Leonurus extract are constituted extract is used as active ingredient.
" health food " refers in this specification, includes (i) Flos puerariae lobatae extract;Or
(ii) Flos Caryophylli extract;And it is female selected from Flos puerariae lobatae extract, burdock extract, Herba Violae extract and benefit
It is fragrant that one or more of the group that careless extract is constituted extract is added to beverage, teas, spice, mouth as active ingredient
In the food materials such as sugar, Dessert, or as the food for being prepared into encapsulated, powdered, suspension etc., when being absorbed pair
Health care belt carrys out specific effect, but from unlike typical medicine, it is using food as raw material, in the absence of having in prolonged administration of drugs
Shi Fasheng side effect etc..The health food of the invention so obtained is realized to oral cavity due to that can be absorbed daily
The excellent effect of disease, thus be highly useful.
By above-mentioned (i) Flos puerariae lobatae extract;Or (ii) Flos Caryophylli extract;And carried selected from Flos puerariae lobatae extract, great burdock achene
One or more of the group of thing, Herba Violae extract and Leonurus extract composition extract is taken to be used as active ingredient
, can be by above-mentioned (i) Flos puerariae lobatae extract in the case of making food additives;Or (ii) Flos Caryophylli extract;And carried selected from flower of kudzuvine
One or more of the group of thing, burdock extract, Herba Violae extract and Leonurus extract composition extract is taken to make
Directly add, or be used together with other food or food composition for active ingredient, can be suitably used according to conventional methods.
The combined amount of active ingredient can suitably be determined according to its application target (prevention, healthy or therapeutic disposal).Generally, in food
During the preparation of product or beverage, composition of the invention is added below 15 parts by weight, below preferably 10 parts by weight relative to raw material
Amount.But, for the taken long-term for the purpose of health and health or for the purpose of health regulation in the case of, above-mentioned amount can be with
It is that below above range, due to any problem being not present in terms of security, active ingredient can also be used more than above range
Amount.Species to above-mentioned food is not particularly limited.There are meat, perfume (or spice) as the example for the food that can add above-mentioned substance
Intestines, bread, chocolate, confectionery, snack class, Dessert, Piza, hand-pulled noodles, other noodles, gummy class including ice cream exist
Interior dairy products, various soup, beverage, tea, decoction agent, alcohol drink and compound vitamin etc., it may include on ordinary meaning
All health foods.The healthy beverage composition of the present invention such as common beverage, can contain multiple scents or natural carbon
Hydrate etc. is used as additional composition.Above-mentioned natural carbohydrate is monose such as glucose, fructose;Such as malt
Sugar, the disaccharides of sucrose and such as polysaccharide of dextrin, cyclodextrin;The sugar alcohols such as xylitol, sorbierite, antierythrite.It is used as sweet taste
Agent, can use such as natural sweetener of Talin, stevia extract or such as synthetic sweetener of saccharin, Aspartame
Deng.The ratio of above-mentioned natural carbohydrate is typically about 0.01~0.04g relative to every composition 100mL of the invention, excellent
Elect about 0.02~0.03g as.Than that described above, health food of the invention can containing a variety of nutritional agents, vitamin, electrolyte,
Flavor enhancement, colouring agent, pectic acid and its salt, alginic acid and its salt, organic acid, protectiveness gum thickener, pH adjusting agent, stably
Carbonating agent used in agent, preservative, glycerine, ethanol, soda etc..In addition, the health food of the present invention can contain useful
In the pulp of the preparation of fruit juice, fruit drink and vegetable beverage.Such composition individually or mixing and use.This
It is 0.01~0.1 parts by weight generally in every parts by weight of composition 100 of the invention though the ratio of the additive of sample is less important
In the range of select.
The present invention's includes (i) Flos puerariae lobatae extract;Or (ii) Flos Caryophylli extract;And selected from Flos puerariae lobatae extract, burdock
One or more of the group that seed extract, Herba Violae extract and Leonurus extract are constituted extract is used as active ingredient
Composition mouth disease prevention or therapeutic effect it is excellent.
In addition, the composition of the present invention is the material that natural products is originated, thus it is nontoxic, also do not lured even if suitable for human body
Side effect is sent out, therefore utilization rate is high.
Brief description of the drawings
Fig. 1 is to confirm the pain of each extract and (each to plant as the chart of the PGE2 of Inflammation Marker suppression effect
" extract " is deleted in thing extract and botanical name is only shown).
Embodiment
Below, to help to understand the present invention, enumerate embodiment etc. and be described in detail.But according to the implementation of the present invention
Example can be deformed into a variety of other forms, should not be construed as the scope of the present invention and be limited to lower embodiment.Embodiments of the invention are used for
Those skilled in the art are more completely illustrated and provided.
Material prepares
The preparation of Flos Caryophylli extract
Gas phase extracting is carried out to cloves and cloves gas phase extract is obtained.
The preparation of Flos puerariae lobatae extract
Flower of kudzuvine is frittered, is impregnated in 95% ethanol solution, is extracted 48 hours at normal temperatures and the extraction of flower of kudzuvine ethanol is obtained
Thing.
The preparation of burdock extract
Great burdock achene is frittered, is impregnated in 95% ethanol solution, extracts 48 hours at normal temperatures and obtains great burdock achene ethanol
Extract.
The preparation of Herba Violae extract
The whole strain of Chinese violet is frittered, is impregnated in 95% ethanol solution, extracts 48 hours at normal temperatures and obtains pale reddish brown
Chinese violet ethanol extract.
The preparation of Leonurus extract
Motherwort is frittered, is impregnated in 95% ethanol solution, extracts 48 hours at normal temperatures and obtains motherwort ethanol
Extract.
Cloves, flower of kudzuvine, great burdock achene, Chinese violet, the preparation of motherwort (five kinds) mixed extract
By it is above-mentioned respectively with extract form prepare cloves, flower of kudzuvine, great burdock achene, Chinese violet, Leonurus extract with
1:1:1:1:1 ratio is injected and prepares cloves, flower of kudzuvine, great burdock achene, Chinese violet, motherwort mixed extract.
The preparation of embodiment and comparative example
The component of the present inventor's table 1 below is prepared for confirming for the embodiment of the effect of mouth disease and right with it
The comparative example toothpaste answered.I.e., first of all for preparing toothpaste, it is (dense using sodium cellulose glycolate, lauryl sodium sulfate, glycerine
Glycerine (98%)), sorbitol aqueous solution (70%), silica-based (sedimentation silica), xanthans, sodium fluoride, spices, sugar
Essence, citric acid etc. prepare comparative example toothpaste, are prepared for the embodiment toothpaste of the mixed extract herein containing 0.01 weight %.
Table 1
Composition name (unit:Weight %) | Embodiment 1 | Embodiment 2 | Comparative example |
Settle silica | 20.0 | 20.0 | 20.0 |
Concentrated glycerin (98%) | 30.0 | 30.0 | 30.0 |
Sorbitol aqueous solution (70%) | 30.0 | 30.0 | 30.0 |
Lauryl sodium sulfate | 1.0 | 1.0 | 1.0 |
Sodium cellulose glycolate | 0.5 | 0.5 | 0.5 |
Xanthans | 0.5 | 0.5 | 0.5 |
Sodium fluoride | 0.22 | 0.22 | 0.22 |
Spices | 1.0 | 1.0 | 1.0 |
Saccharin | 1.0 | 1.0 | 1.0 |
Citric acid, triethanolamine (TEA) | In right amount | In right amount | In right amount |
Mixed extract | 0.01 | - | - |
Flos puerariae lobatae extract | - | 0.01 | - |
Purified water | To 100 | To 100 | To 100 |
The > of < experimental examples 1
Antibacterial effect confirms
The present inventor is come to confirm the excellent antibacterial effect of mixed extract using paper dish (paper disk) determination method
Implement antibacterial activity test, judge to use the gram-positive bacteria Streptococcus mutans that Induction of bacterial is represented as carious tooth and periodontosis
And as gram-negative bacteria porphyromonas gingivalis whether have suppress bacterial strain effect.Above-mentioned each bacterium is in table 2 below
Optimal culture condition under cultivate activity after, in the optimal medium of each bacterium cultivate 4~6 hours or so, adjust nutrient solution
Turbidity become Macfarland turbidity No.0.5 (1.5 × 108) after, equably smear 0.1ml.In sterilizing
Paper dish (Whatman no.5paper, 8mm diameter) in, every (table 3) extract is connect with 10mg/disc concentration
Kind, absorb and used after drying 1 hour.After being cultivated 24~48 hours in the optimum temperature of above-mentioned each bacterium, growth is determined low
The size (diameter mm) of alicyclic ring.
Table 2
Its result is illustrated in table 3 below (omission shows " extract " in each plant extracts in lower item).
Table 3
As a result, can confirm that out in above-mentioned table 3, cloves, flower of kudzuvine, Chinese violet, great burdock achene and Leonurus extract
In, the growth low fat ring of Flos puerariae lobatae extract is revealed as most wide.
It can confirm that out in addition, compared with each extract, the growth in the mixed extract comprising Flos Caryophylli extract is low
Alicyclic ring diameter is revealed as excellent effect, includes the whole life of cloves, flower of kudzuvine, Chinese violet, great burdock achene and Leonurus extract
Long low fat ring diameter is most wide for Streptococcus mutans and porphyromonas gingivalis.
The > of < experimental examples 2
PGE2 inhibitions confirm
The present inventor is in order to confirm the toothache remission effect of mixed extract, it is thus identified that be used as pain and Inflammation Marker
PGE2 suppression effect.With 1.5 × 10 in the DMEM culture mediums of the macrophage comprising 10%FBS5Cells/ml concentration is entered
Row inoculation, with 37 DEG C, 5%CO2Condition was in 24 orifice plate culture 24 hours.Then, inflammation is induced stimulates reason creotoxin (LPS)
1 μ g/ml and each extract are handled, and PGE2 inhibitory action is have rated with the culture upper liquid of 24 hours.Its result is shown
For Fig. 1.
As a result, as can confirm that out in above-mentioned Fig. 1, compared with each extract, the mixing comprising Flos Caryophylli extract is carried
Thing is taken to show excellent effect comprising the whole effect of cloves, flower of kudzuvine, Chinese violet, great burdock achene and Leonurus extract
Fruit is the most excellent.
The > of < experimental examples 3
Gingivitis formation inhibition confirms
The present inventor has used the embodiment and comparative example tooth of above-mentioned table 1 to confirm gingivitis formation inhibition
Cream.Experimental subjects is so that denture is neat, tooth N/D gingivitis patient as object, according to the age from 30 years old to 50 years old, with
It is within 10 years old interval, according to sex, accurate dental examination is implemented to every 30, selects after 120 experimental subjects groups, be divided into each
60, perform the clinical trial to gingivitis therapeutic effect.
It is experimental group (embodiment) and control group (comparative example) by experimental subjects component, after the meal after 2 hours, makes it
Used 3 times daily before sleep, implement scaling, fractionation is carried out to initial gingivitis indices, it is used each toothpaste group
Compound, after by 1 week, 1 month, 3 months and 6 months, implements dental examination, and check gingivitis indices.Gingivitis
The assay method of index is to insert periodontal probe (periodontal probe) in gingival sulcus, with the state of not applying power, combustion
Burn around each tooth, carry out probe, after by 30 seconds, determine the state of bleeding, the standard recording fraction shown in table 4 below
And obtain result.
The results are shown in table 5.
Table 4
Fraction | Content |
0 point | Without bleeding state |
1 point | Normal bleeding state |
2 points | Streak-like hemorrhage state |
3 points | Triangle bleeding state in position between tooth |
4 points | Gum entirety bleeding state |
Table 5
Period | Control group | Experimental group |
0 week | 1.05 | 1.05 |
1 week | 1.51 | 1.05 |
1 month | 2.64 | 1.08 |
3 months | 2.79 | 1.08 |
6 months | 2.83 | 1.09 |
As a result, can confirm that out from shown in above-mentioned table 5, in the case of using the experimental group of embodiment toothpaste for,
It has passed through after 6 months, gingivitis indices almost do not rise with preliminary phase than also, for the feelings of the control group using comparative example toothpaste
For condition, starting after 1 week, gingivitis indices sharp rise, formed so as to can not suppress gingivitis.
Thus, confirming the composition of the present invention has excellent gingivitis formation inhibition.
The > of < experimental examples 4
Hemodia inhibition confirms
The present inventor has used the embodiment and comparative example toothpaste of above-mentioned table 1 to confirm hemodia inhibition.Will
With hyperesthesia tooth and agree to participate in the volunteer 40 of this experiment as research object, ultimate survey target tooth is 80
.In addition, male is 20 in volunteer, women is 20, and the age was from 20 years old to 50 years old.Research object is set to be unaware of in toothpaste
Tolerant, total experimental period is set to two weeks.(experimental group 1:Embodiment, experimental group 2:Embodiment 2, control group:Comparative example).
Experiment is implemented using the method for measure reaction after thermal stimulus is applied.Before experiment is implemented, in advance
The allergy position of the hyperesthesia tooth of each volunteer is first checked, about 5 DEG C cool is added dropwise at the allergy position of tooth with minim pipette
Water, after being scored, makes it, daily using 3 each compositions, after two weeks, minim pipette be used again during two weeks
About 5 DEG C of cold water is added dropwise to be scored.Post-stimulatory reaction standards of grading setting is as follows.(0 point:Without any discomfort
Sense, 1 point:Slightly feel uncomfortable or cool, 3 points:Pain).As statistical disposition, the stimulation fraction profit before implementation and after two weeks will be tested
Verified with paired student-t test.
The fraction reacted to thermal stimulus after two weeks is illustrated in table 6 below.
Table 6
Period | Control group | Experimental group 1 | Experimental group 2 |
0 week | 2.14±0.14 | 2.13±0.20 | 2.14±0.06 |
Two weeks | 2.15±0.21 | 1.72±0.09 | 1.55±0.28 |
P > 0.05 | * p < 0.05 | * p < 0.05 |
As a result, can confirm that out from shown in above-mentioned table 6, initial stage control group and experimental group in the reaction on thermal stimulus
Larger difference is not present on fraction, but after two weeks, does not show difference in control group, and in the case of experimental group, instead
Fraction is answered meaningfully to reduce.
That is, confirm that excellent hemodia suppresses to imitate using the embodiment toothpaste of the mixed extract comprising the present invention
Really.In the case of the independent treatment group of flower of kudzuvine, it can be identified that going out with excellent hemodia inhibition.
The > of < experimental examples 5
Halitosis removal effect confirms
The present inventor has used the embodiment and comparative example toothpaste of above-mentioned table 1 to confirm halitosis removal effect.
50 men and women of no carious tooth disease are selected, intersection is implemented to target beverage and tests (Cross-over repeatedly
test).Commercially available garlic powder is dispersed in water, after placing 24 hours, is diluted, makes halimeter (Halimeter)
Measured value turns into more than 700ppb, and above-mentioned dilution then is used as into halitosis induces source.Gargle 30 with garlic powder dilution 15ml
Second, with after halimeter measure halitosis degree after 1 minute, use experimental group and control group (experimental group 1:Embodiment, experiment
Group 2:Embodiment 2, control group:Comparative example) toothpaste carry out gargle within 30 seconds~1 minute.After gargling, by 1 minute, 5 minutes,
After 30 minutes, halitosis degree is determined with halimeter to determine halitosis suppresses whether to continue.
Its result is illustrated in table 7 below.
Table 7
Period | Control group | Experimental group | Experimental group 2 |
1 minute | 55.8% | 96.9% | 96.8% |
5 minutes | 45.1% | 87.2% | 87.9% |
30 minutes | 37.2% | 85.6% | 82.4% |
As a result, can confirm that out from shown in above-mentioned table 7, the experimental group of embodiment toothpaste has been used compared to having used ratio
Control group compared with example toothpaste shows excellent halitosis inhibition.In the case of the independent treatment group of flower of kudzuvine, it can be identified that
Go out with excellent halitosis inhibition.
Claims (13)
1. a kind of composition for being used to preventing or treating mouth disease, it is used as active ingredient comprising Flos puerariae lobatae extract.
2. a kind of be used to preventing or treating the composition of mouth disease, it is comprising Flos puerariae lobatae extract and Flos Caryophylli extract as having
Imitate composition.
3. a kind of be used to preventing or treating the composition of mouth disease, its comprising Flos Caryophylli extract and selected from Flos puerariae lobatae extract,
One or more of the group that burdock extract, Herba Violae extract and Leonurus extract are constituted extract is as effective
Composition.
4. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3, its
In, the mouth disease is mucosal ulcer, halitosis and hemodia in toothache, carious tooth, gingivitis, periodontitis, oral cavity
One or more of group of composition disease.
5. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3, its
In, the mouth disease is gingivitis or periodontitis.
6. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3, its
In, the active ingredient includes 0.0001 weight % to 10 weight % relative to the composition total weight.
7. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3, its
In, the active ingredient includes 0.001 weight % to 1 weight % relative to the composition total weight.
8. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3, its
In, the composition has antibacterial effect to streptococcus or porphyromonas accessory.
9. the composition according to claim 8 for being used to preventing or treating mouth disease, wherein, the streptococcus is change
Different streptococcus.
10. the composition according to claim 8 for being used to preventing or treating mouth disease, wherein, the porphyromonas category
For porphyromonas gingivalis.
11. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3,
Wherein, the composition is used as composition for oral cavity, cosmetic composition, pharmaceutical composition or health-care food composition.
12. the composition of mouth disease is prevented or treated to being used for according to any one of claim 1 to claim 3,
Wherein, the extract is to utilize to be selected from water, distilled water, methanol, ethanol, propyl alcohol, isopropanol, butanol, acetone, ether, benzene, chlorine
In the group that imitative, ethyl acetate, dichloromethane, n-hexane, hydrochloric acid, acetic acid, formic acid, diethyl ether and hexamethylene are constituted it is a kind of with
Upper solvent extraction.
13. the composition according to claim 11 for being used to preventing or treating mouth disease, wherein, the oral composition
Thing has to be constituted selected from toothpaste, mouthwass, oral cavity spray liquid, oral cavity ointment, oral cavity paster and chewing gum
One or more of group formulation.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160041725A KR101881636B1 (en) | 2016-04-05 | 2016-04-05 | Composition for prevention or treatment of oral disease comprising Pueraria Extract |
KR10-2016-0041725 | 2016-04-05 | ||
KR10-2016-0076736 | 2016-06-20 | ||
KR1020160076736A KR102070316B1 (en) | 2016-06-20 | 2016-06-20 | Composition for treating or preventing oral diseases comprising natural complex |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107260792A true CN107260792A (en) | 2017-10-20 |
CN107260792B CN107260792B (en) | 2022-03-18 |
Family
ID=60073559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710202985.XA Active CN107260792B (en) | 2016-04-05 | 2017-03-30 | Composition for preventing or treating oral diseases comprising natural complex |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107260792B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403514A (en) * | 2018-05-02 | 2018-08-17 | 山东胜伟旅游发展有限公司 | The preparation method of toothpaste containing salt-soda soil burdock extract |
CN113491641A (en) * | 2020-03-19 | 2021-10-12 | 株式会社Lg生活健康 | Composition containing pueraria flower glucoside |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1341449A (en) * | 2001-09-30 | 2002-03-27 | 陈新 | Perlingual sweets for relieving acute alcoholism and its preparation method |
CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
KR100431170B1 (en) * | 2003-06-11 | 2004-05-12 | 신화제약 (주) | Compositions for Dental Clinic Comprising Extracts of Plant |
KR20110088978A (en) * | 2010-01-29 | 2011-08-04 | 애경산업(주) | Oral composition containing herbal extract |
KR101293335B1 (en) * | 2011-11-16 | 2013-08-06 | 한승국 | The liquefied dentifrice making method besides |
-
2017
- 2017-03-30 CN CN201710202985.XA patent/CN107260792B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1341449A (en) * | 2001-09-30 | 2002-03-27 | 陈新 | Perlingual sweets for relieving acute alcoholism and its preparation method |
CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
KR100431170B1 (en) * | 2003-06-11 | 2004-05-12 | 신화제약 (주) | Compositions for Dental Clinic Comprising Extracts of Plant |
KR20110088978A (en) * | 2010-01-29 | 2011-08-04 | 애경산업(주) | Oral composition containing herbal extract |
KR101293335B1 (en) * | 2011-11-16 | 2013-08-06 | 한승국 | The liquefied dentifrice making method besides |
Non-Patent Citations (8)
Title |
---|
JONATAS RAFAEL DE OLIVEIRA,等: ""Control of microorganisms of oral health interest with Arctium lappa L. (burdock) extract non-cytotoxic to cell culture of macrophages(RAW 264.7)"", 《ARCHIVES OF ORAL BIOLOGY》 * |
YOUNG-SOOK HAN等: ""Antibacterial Activities of Flower Tea Extracts against Oral Bacteria"", 《KOREAN J. FOOD COOKERY SCI.》 * |
周德生、谭生元主编: "《简明中药手册》", 31 January 2014, 山西科学出版社 * |
曾晓虎,主编: "《中西汇通中药手册》", 31 May 2006, 人民军医出版社 * |
李克绍,著: "《中药讲习手记》", 30 June 2012, 中国医药科技出版社 * |
李艳红,等: ""丁香对口腔优势菌生长影响的体外研究"", 《昆明医科大学学报》 * |
武文慧,主编: "《营养治病》", 31 January 2011, 中央编译出版社 * |
王绪前,编著: "《中医食疗》", 31 October 2015, 中国中医药出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403514A (en) * | 2018-05-02 | 2018-08-17 | 山东胜伟旅游发展有限公司 | The preparation method of toothpaste containing salt-soda soil burdock extract |
CN113491641A (en) * | 2020-03-19 | 2021-10-12 | 株式会社Lg生活健康 | Composition containing pueraria flower glucoside |
Also Published As
Publication number | Publication date |
---|---|
CN107260792B (en) | 2022-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070110684A1 (en) | Morinda Citrifolia-Based Oral Care Compositions and Methods | |
TW201200161A (en) | Oral compositions containing extracts of Zizyphus joazeiro and related methods | |
TW201141502A (en) | Oral compositions containing extracts of zingiber officinale and related methods | |
CN109843264A (en) | A kind of dentifrice composition containing herb extracts | |
JP2008156325A (en) | External preparation for skin and skin-lightening agent | |
KR20180108331A (en) | Method for improving periodontitis and alveolar bone loss of complex extracts of Moringa leaf and Eucommia Bark by anti-bacterial, antioxidant, anti-inflammatory, antioxidant effects and inhibition of alveolar bone loss | |
CN106535911B (en) | Oral composition for preventing and treating periodontitis containing cortex Mori extract and Euonymus Alata Sieb extract as active ingredients | |
KR102408893B1 (en) | Composition for prevention or treatment of oral disease comprising Pueraria Extract | |
KR100561780B1 (en) | Cosmetic compositions for anti-irritation containing ponciri fructus extracts as effective ingredients | |
CN107260792A (en) | The composition of mouth disease is prevented or treated to being used for comprising natural complex | |
KR102562835B1 (en) | Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract | |
KR20160081204A (en) | Composition for improving hair and scalp condition coprising extract of hydrangea serrata | |
KR102070316B1 (en) | Composition for treating or preventing oral diseases comprising natural complex | |
CN107073061B (en) | Oral composition for preventing and treating dental caries comprising cortex Mori extract and Euonymus Alata Sieb extract as active ingredients | |
CN110613801B (en) | Oral composition for preventing or improving oral diseases and use thereof | |
KR20220110700A (en) | Oral composition | |
KR20150108610A (en) | Anti-acnes Cosmetics having herb medicine | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR101978742B1 (en) | Composition for improving sleep comprising natural herbal medicine materials | |
KR102415612B1 (en) | Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract | |
KR102520908B1 (en) | Preparation of aged solution of fruit of dioscorea opposita thumb, and aged solution of fruit of dioscorea opposita thumb prepared thereby | |
KR102548925B1 (en) | Composition for prevention or treatment of oral disease comprising Scopoletin | |
CN110115720A (en) | Mouth disease prevention or therapeutic composition comprising Herba Epimedii herb extract | |
KR102562829B1 (en) | Composition for prevention or treatment of oral disease comprising Alpinia officinarum Extract | |
KR102562830B1 (en) | Composition for prevention or treatment of oral disease comprising Kochiae Fructus Extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |